Interest of New MRI Sequences After Embolization of Brain Arteriovenous Malformations (MAV-IRM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02896881|
Recruitment Status : Recruiting
First Posted : September 12, 2016
Last Update Posted : March 13, 2018
In previous studies exploring specific sequences of MRI (susceptibility weighted imaging (SWI) and arterial spin labeling (ASL)), the investigators have shown the great sensibility of these MRI sequences to detect arteriovenous shunts, compared to angiography imaging (static or dynamic).
This prospective study aims to compare multisequence MRI to brain arteriography imaging in patients undergoing brain arteriovenous malformations embolization.
|Condition or disease|
|Brain Arteriovenous Malformations|
|Study Type :||Observational|
|Estimated Enrollment :||75 participants|
|Official Title:||Interest of New MRI Sequences After Embolization of Brain Arteriovenous Malformations (MAV-IRM)|
|Actual Study Start Date :||February 1, 2017|
|Estimated Primary Completion Date :||February 2019|
|Estimated Study Completion Date :||February 2019|
- sensitivity of multisequence MRI to detect a residual arteriovenous malformation after embolization [ Time Frame: within 3 months after embolization ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02896881
|Contact: Laurence SALOMON, MD, PhDemail@example.com|
|Fondation Opthalmologique A de Rothschild||Recruiting|
|Paris, France, 75019|
|Contact: Raphaël BLANC firstname.lastname@example.org|
|Principal Investigator:||Raphaël BLANC, MD||Fondation Ophtalmologique Adolphe de Rothschild|